# Ibuprofen Bioavailability Trial With Oral Single Dose Administration.

> **NCT03018015** · PHASE1 · COMPLETED · sponsor: **SocraTec R&D GmbH** · enrollment: 30 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Ibuprofen 400 mg oral powder
- **DRUG:** Ibuprofen 400 mg film-coated tablet
- **DRUG:** Ibuprofen 400 mg soft capsule

## Key facts

- **NCT ID:** NCT03018015
- **Lead sponsor:** SocraTec R&D GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03018015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03018015, "Ibuprofen Bioavailability Trial With Oral Single Dose Administration.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03018015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*